| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/06/2011 | US8012482 Humanized anti-TGF-beta antibodies |
| 09/06/2011 | US8012479 Recombinant toxin fragments |
| 09/06/2011 | US8012478 Use of anti-IL-20 antibody for treating stroke |
| 09/06/2011 | US8012477 Methods of treating multiple myeloma using IL-17 binding molecules |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | US8012475 Use of IL-12 and IL-12 antagonists in the treatment of autoimmune diseases |
| 09/06/2011 | US8012474 Anti-RANTES antibodies |
| 09/06/2011 | US8012473 C3b antibodies and methods for the prevention and treatment of complement-associated disorders |
| 09/06/2011 | US8012472 Suppressing fibrosis in a mammal having a fibrosing disease by administering a Serum Amyloid P (SAP) protein; treatment of diseases such as scleroderma, pulmonary fibrosis and asthma |
| 09/06/2011 | US8012470 Method for ex vivo immunization using heterologous intact bispecific and/or trispecific antibodies |
| 09/06/2011 | US8012469 Universal GM-CSF expressing bystander human K562 cell line |
| 09/06/2011 | US8012468 Dendrite cells transduced with recombinant adenovirus AdVCEA which generate CEA-specific cytotoxic T lymphocytes, vaccine and pharmaceutical composition comprising the same |
| 09/06/2011 | US8012467 Multivalent vaccines comprising recombinant viral vectors |
| 09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
| 09/06/2011 | CA2559633C Vaccine compositions obtained from streptomyces |
| 09/06/2011 | CA2533877C Safe mutant viral vaccines |
| 09/06/2011 | CA2463085C Vaccines against arthropod-borne infectious diseases |
| 09/06/2011 | CA2427578C A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine |
| 09/06/2011 | CA2335230C Regions of papilloma virus e1 helicase involved in e1 oligomerization |
| 09/01/2011 | WO2011106743A1 Recombinant cdv compositions and uses thereof |
| 09/01/2011 | WO2011106723A2 Anti-paf antibodies |
| 09/01/2011 | WO2011106707A2 Antibodies that specifically bind to dr3 |
| 09/01/2011 | WO2011106705A2 Dna-protein vaccination protocols |
| 09/01/2011 | WO2011106697A1 Therapeutic compositions for the treatment of dry eye disease |
| 09/01/2011 | WO2011106645A1 Direct analysis of antigen-specific immune response |
| 09/01/2011 | WO2011106607A2 Subunit vaccines for herpes viruses and methods of use |
| 09/01/2011 | WO2011106528A1 Folate receptor 1 antibodies and immunoconjugates and uses thereof |
| 09/01/2011 | WO2011106376A2 Use of microvesicles in the treatment of medical conditions |
| 09/01/2011 | WO2011105891A1 Combination vaccine for streptococcus |
| 09/01/2011 | WO2011105573A1 Anti-icam3 antibody and use thereof |
| 09/01/2011 | WO2011105551A1 Method for detection of cancer stem cell, and therapeutic agent or recurrence-preventing agent for cancer |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | WO2011105424A1 Dendritic cell immunoreceptor stimulant |
| 09/01/2011 | WO2011104687A1 Antagonist anti-il-7 receptor antibodies and methods |
| 09/01/2011 | WO2011104684A1 Proteins/peptides having immunogenic properties and their biological applications |
| 09/01/2011 | WO2011104632A1 Immunogenic proteins and compositions |
| 09/01/2011 | WO2011104558A1 Cancer vaccine |
| 09/01/2011 | WO2011104557A1 Protein formulations |
| 09/01/2011 | WO2011104497A1 Method for the preparation of a novel nanoparticle conjugate |
| 09/01/2011 | WO2011104381A2 Stable antibody containing compositions |
| 09/01/2011 | WO2011104315A2 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 09/01/2011 | WO2011103794A1 Spray for treating diseases caused by human papilloma virus and preparation method thereof |
| 09/01/2011 | WO2011103771A1 Sterilized natural antigen mixture for prevention and treatment of allergy |
| 09/01/2011 | WO2011103702A1 Fully human monoclonal antibody to vegf, preparation method and use thereof |
| 09/01/2011 | WO2011103701A1 Full human anti-tnf- alpha monoclonal antibody, preparation method and use thereof |
| 09/01/2011 | WO2011103667A1 Agonistic antibodies to trkb receptors and uses thereof |
| 09/01/2011 | WO2011103633A1 Treatment or prevention of infection |
| 09/01/2011 | WO2011085231A3 Synthetic virus-like particles conjugated to human papillomavirus capsid peptides for use as vaccines |
| 09/01/2011 | WO2011043584A9 Highly pathogenic avian influenza virus protein vaccine derived from transgenic plants, and method for preparing same |
| 09/01/2011 | US20110214194 Compositions and methods for modulating cells via cd14 and toll-like receptor 4 signaling pathway |
| 09/01/2011 | US20110213337 Methods for the early diagnosis of ovarian cancer |
| 09/01/2011 | US20110213130 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 09/01/2011 | US20110213129 Diagnostics and treatments of periodontal disease |
| 09/01/2011 | US20110212449 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
| 09/01/2011 | US20110212168 Composition for targeting dendritic cells |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212161 Treatment skin disorders |
| 09/01/2011 | US20110212159 Vaccines |
| 09/01/2011 | US20110212157 Dermal delivery |
| 09/01/2011 | US20110212136 Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury |
| 09/01/2011 | US20110212135 Oligodeoxynucleotide and its use to induce an immune response |
| 09/01/2011 | US20110212134 Anti-arthropod vector vaccines, methods of selecting and uses thereof |
| 09/01/2011 | US20110212133 Novel Methods of Diagnosis and Treatment of P. Aeruginosa Infection and Reagents Therefor |
| 09/01/2011 | US20110212132 Pathogen for bacterial poultry disease |
| 09/01/2011 | US20110212131 Method for enhancing an immune response |
| 09/01/2011 | US20110212130 Live, attenuated respiratory syncytial virus |
| 09/01/2011 | US20110212129 Method for Producing the Flu Virus |
| 09/01/2011 | US20110212128 Universal virus-like particle (VLP) influenza vaccines |
| 09/01/2011 | US20110212127 Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine |
| 09/01/2011 | US20110212126 Inactivated chimeric vaccines and related methods of use |
| 09/01/2011 | US20110212125 Vaccine for shigella |
| 09/01/2011 | US20110212124 Vaccine Composition |
| 09/01/2011 | US20110212123 Immunogenic Substances Comprising a Polyinosinic Acid - Polycytidilic Acid Based Adjuvant |
| 09/01/2011 | US20110212122 Nerve Growth Factor Conjugates and Uses Thereof |
| 09/01/2011 | US20110212121 Recombinant chimeric antigens for diagnosis and prevention of scrub typhus |
| 09/01/2011 | US20110212120 Ykur polynucleotides and polypeptides |
| 09/01/2011 | US20110212119 Methods for making hiv vaccines and related compositions |
| 09/01/2011 | US20110212118 TAT Protein for preventing or treating AIDS |
| 09/01/2011 | US20110212117 Influenza hemagglutinin and neuraminidase variants |
| 09/01/2011 | US20110212116 Immunogenic peptides and uses thereof |
| 09/01/2011 | US20110212115 Melk epitope peptides and vaccines containing the same |
| 09/01/2011 | US20110212114 Method for making targeted therapeutic agents |
| 09/01/2011 | US20110212113 Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent |
| 09/01/2011 | US20110212112 Conformation specific antibodies |
| 09/01/2011 | US20110212111 MHC II Associated Protein and Uses Thereof |
| 09/01/2011 | US20110212110 Compositions and Methods for Detecting TLR3 |
| 09/01/2011 | US20110212109 Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES |
| 09/01/2011 | US20110212108 Neuregulin/erbb signaling and integrin |
| 09/01/2011 | US20110212107 Juvenile hemochromatosis gene (HFE2A) cleavage products and uses thereof |
| 09/01/2011 | US20110212106 Hiv-1 neutralizing antibodies and uses thereof |
| 09/01/2011 | US20110212105 Method to block the infection by flaviviruses, molecules and uses |
| 09/01/2011 | US20110212104 Inflammatory bowel disease biomarkers and related methods of treatment |
| 09/01/2011 | US20110212103 Thienopyrimidines containing a substituted alkyl group for pharmaceutical compositions |
| 09/01/2011 | US20110212102 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 09/01/2011 | US20110212101 Materials and methods for exploiting synthetic lethality in mismatch repair-deficient cancers |
| 09/01/2011 | US20110212100 Methods for modulating development and expansion of il-17 expressing cells |
| 09/01/2011 | US20110212099 Methods of modulating il-22 and il-17 |
| 09/01/2011 | US20110212098 Novel Melanoma Antigen Peptide and Uses Thereof |
| 09/01/2011 | US20110212097 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated Diseases |
| 09/01/2011 | US20110212096 Anti-p-selectin antibodies and methods of their use and identification |